Induction of Long-Term Memory CD8+T Cells for Recall of Viral Clearing Responses against Influenza Virus
Open Access
- 1 May 2002
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 76 (9) , 4212-4221
- https://doi.org/10.1128/jvi.76.9.4212-4221.2002
Abstract
Induction of cytotoxic T-cell-mediated virus-clearing responses by influenza virus T cell determinant-containing peptide immunogens was examined. The most potent synthetic immunogens for eliciting pulmonary viral-clearing responses contained peptides representing determinants for CD4 and CD8 T cells (TH and CTL peptides, respectively) together with two or four palmitic acid (Pal) groups. Inoculated in adjuvant, these Pal2- or Pal4-CTL-TH lipopeptides and the nonlipidated CTL peptide induced equivalent levels of cytolytic activity in the primary effector phase of the response. The ability to recall lytic responses, however, diminished much more rapidly in CTL peptide-primed than in lipopeptide-primed mice. By 15 months postpriming, the recalled lytic activity in lipopeptide-inoculated mice remained potent, but the response induced by the CTL peptide was weak. Enumeration of specific gamma interferon-secreting CD8 T cells revealed that a greater number of these T cells had entered or remained in the memory pool in lipopeptide-primed mice, arguing for a quantitative rather than qualitative enhancement of the response on recall. Addition of either the lipid or the TH peptide to the CTL peptide was not sufficient to provide these long-lived antiviral responses, but inclusion of both components augmented the response. CD4 T cells elicited by the lipopeptides did not influence the rate of viral clearance upon challenge and most likely had a role in induction or maintenance of the memory response. It therefore appears that the lipopeptide immunogens, although not significantly superior at inducing primary effector CD8 T cells, elicit a much more effective memory population, the recall of which may account for their superiority in inducing pulmonary protection after viral challenge.Keywords
This publication has 56 references indexed in Scilit:
- Diminished Primary and Secondary Influenza Virus-Specific CD8+T-Cell Responses in CD4-Depleted Ig−/−MiceJournal of Virology, 2000
- Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzeesEuropean Journal of Immunology, 1997
- Novel adjuvants and vaccine delivery systemsVeterinary Immunology and Immunopathology, 1996
- Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptidesInternational Immunology, 1996
- Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptidesVaccine, 1996
- Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.Journal of Clinical Investigation, 1995
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Vaccination of class I major histocompatibility complex (MHC)‐restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating‐ovalbumin complexes enter the class I MHC‐restricted antigen pathway and allow sensitization against the immunodominant peptideEuropean Journal of Immunology, 1991
- Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide.The Journal of Experimental Medicine, 1990
- Introduction of soluble protein into the class I pathway of antigen processing and presentationCell, 1988